The latest closing stock price for NeuroSense Therapeutics as of September 18, 2024 is 1.35.
An investor who bought $1,000 worth of NeuroSense Therapeutics stock at the IPO in 2021 would have $-666 today, roughly -1 times their original investment - a -30.61% compound annual growth rate over 3 years.
The all-time high NeuroSense Therapeutics stock closing price was 6.23 on March 21, 2022.
The NeuroSense Therapeutics 52-week high stock price is 2.33, which is 72.6% above the current share price.
The NeuroSense Therapeutics 52-week low stock price is 0.40, which is 70.4% below the current share price.
The average NeuroSense Therapeutics stock price for the last 52 weeks is 1.04.
An investor who bought $1,000 worth of NeuroSense Therapeutics stock at the IPO in 2021 would have $-666 today, roughly -1 times their original investment - a -30.61% compound annual growth rate over 3 years.
The all-time high NeuroSense Therapeutics stock closing price was 6.23 on March 21, 2022.
The NeuroSense Therapeutics 52-week high stock price is 2.33, which is 72.6% above the current share price.
The NeuroSense Therapeutics 52-week low stock price is 0.40, which is 70.4% below the current share price.
The average NeuroSense Therapeutics stock price for the last 52 weeks is 1.04.